TL;DR
Get health and wellness essentials delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
Researchers report that the enzyme Pla2g2f was associated with protection against several aging-related brain changes in mice, including memory impairment. The study also found Pla2g2f activity reduced lipid-droplet accumulation in human microglia in laboratory experiments, but it does not establish a treatment for people.
Researchers report that increasing the brain enzyme Pla2g2f protected aging mice from several changes linked to cognitive decline, including memory impairment, in a study published in Nature Neuroscience. The findings also link the enzyme to reduced lipid-droplet accumulation in human microglia grown for research, but they do not show that boosting it can prevent or treat cognitive decline in people.
The study, led by Cinzia Vicidomini, PhD, and Amar Sahay, PhD, examined genes activated in response to synapse loss in the hippocampus, a brain region important for memory. The researchers identified Pla2g2f, which produces a secreted phospholipase enzyme whose role in the brain had not previously been established, according to the report.
In aging mice, Pla2g2f levels rose in the hippocampus, including under conditions of brain inflammation. The team used genetic and viral methods to alter the gene’s levels. Reducing Pla2g2f worsened several features associated with brain aging: synapse loss, inflammation, impaired maturation of new brain cells, disrupted lipid metabolism, lipid-droplet accumulation in neurons and microglia, and memory impairment. Increasing its levels protected against many of these changes and helped preserve memory.
The researchers also reported that raising Pla2g2f activity in human microglia reduced lipid droplets and cholesterol esters in laboratory experiments. These cellular findings are not evidence of a benefit in patients. The paper, An aging-sensitive secreted phospholipase confers neuroprotection and cognitive resilience, was published in October 2026 and has the DOI 10.1038/s41593-026-02465-z.
How Pla2g2f May Protect Memory
The findings point to a possible biological mechanism that helps the aging brain withstand damage. The reported effects span synapse maintenance, inflammation and lipid handling, rather than memory alone. That breadth may help researchers investigate how several aging-related processes interact, and whether protective responses can be supported before substantial cognitive problems appear.
The team found that boosting Pla2g2f in middle-aged mice, before substantial cognitive decline had developed, changed the trajectory of age-related memory loss. This suggests a possible prevention-oriented research direction, but the result comes from mice and cannot establish that the same intervention would work, or be safe, in people. The human microglia experiments add a separate line of laboratory evidence, not a clinical outcome.
Aging is a major risk factor for Alzheimer’s disease, but the study does not show that Pla2g2f prevents Alzheimer’s or mild cognitive impairment. Its importance is as an early research lead: identifying a protective factor could inform future studies of resilience, while any patient treatment would require further testing.
brain health supplements for memory
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
The Study’s Path From Synapses
The research began with a focus on synapse loss in the hippocampus, which the authors describe as a defining feature of age-related cognitive decline. Rather than starting with a proposed therapy, the team sought genes that respond to synapse loss in mice. That approach led them to Pla2g2f and to experiments testing what happened when its levels were lowered or raised.
The work addresses a broader question about brain aging: why some brains retain cognitive function despite biological changes associated with disease. The researchers report that Pla2g2f levels increased in older adults whose brains showed signs of Alzheimer’s pathology but who remained cognitively resilient. This observation is an association in people; the experimental changes to Pla2g2f and the reported memory effects were tested in mice.
The study also examined microglia, immune cells in the brain. The researchers describe lipid-droplet buildup in these cells as a feature associated with reduced ability to clear waste, maintain synapses and support neurons. Their experiments connect Pla2g2f with lipid regulation, but do not establish that the enzyme is the sole cause of these processes or that changing it will alter disease in humans.
“We sought to identify the protective factors that contribute to cognitive resilience during aging.”
— Cinzia Vicidomini, PhD, and Amar Sahay, PhD, the study’s lead and senior authors, in the News-Medical report
As an affiliate, we earn on qualifying purchases.
Human Benefits Remain Untested
The available findings do not establish whether increasing Pla2g2f can safely preserve memory or reduce disease risk in people. The memory experiments described were conducted in mice, while the human work involved microglia in laboratory experiments. The report does not describe a clinical trial or patient treatment results.
It also remains unclear how Pla2g2f activity could be safely increased in the aging human brain, what dose or timing might be appropriate, and whether any benefit would outweigh possible risks. The researchers say they are exploring ways to increase levels, but the source provides no tested intervention, clinical timeline or evidence that the enzyme would delay Alzheimer’s disease in patients.
cognitive decline prevention supplements
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Testing a Safe Route Forward
The researchers say they are exploring potential ways to safely increase Pla2g2f levels in the aging brain and in Alzheimer’s disease. The next steps would need to establish how the enzyme works across relevant brain processes, whether the mouse findings can be reproduced, and whether an approach can reach its target without harmful effects.
Before the work could support a patient therapy, studies would need to test safety and effectiveness in people. Until then, Pla2g2f is a research target, not an available or proven means of preventing cognitive decline. The source material does not give a schedule for follow-up studies or clinical trials.
neuroprotective enzyme supplements
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Key Questions
What is Pla2g2f?
Pla2g2f is a gene that produces a secreted phospholipase enzyme. The researchers investigated its role in the brain after identifying it in a study of genes responding to synapse loss.
Did the enzyme prevent memory loss in people?
No such effect has been shown. The reported memory findings came from aging mice. Human experiments described in the report used microglia in laboratory conditions, not patients receiving treatment.
What happened when researchers increased Pla2g2f in mice?
Increasing Pla2g2f protected against several aging-related brain changes and helped preserve memory. The researchers also reported that boosting it in middle-aged mice changed the trajectory of age-related memory loss.
Could this lead to an Alzheimer’s treatment?
The authors say the findings may point toward a possible therapeutic strategy, but no treatment has been established. Further research is needed to determine whether Pla2g2f can be increased safely and whether doing so benefits people.
Source: rss
Fall Picks
fall essentials
As an affiliate, we earn on qualifying purchases.
